Pmsc-Venlafaxine XR 150 mg (Venlafaxine (Venlafaxine Hydrochloride) CAPSULE (EXTENDED RELEASE)) 150 MG

Venlafaxine XR 150 mg extended-release capsules are used to manage depression and anxiety. This selective serotonin-norepinephrine reuptake inhibitor (SNRI) offers long-lasting relief with once-daily dosing.

Strength

150 MG

Manufacturer / TM Owner

PHARMASCIENCE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Venlafaxine XR 150 mg is primarily used to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). It works by balancing certain natural substances in the brain, helping to improve mood and reduce anxiety. This medication is often prescribed for individuals who require sustained symptom control throughout the day.

Side Effects

Common effects of Venlafaxine XR 150 mg may include nausea, dizziness, and dry mouth. Some users also report fatigue, insomnia, or constipation. These effects are typically mild and may diminish as the body adjusts to the medication.

Precautions & Warnings

Venlafaxine XR 150 mg should be taken exactly as directed by a healthcare provider. It is important to avoid crushing or chewing the capsules to maintain their extended-release properties. Patients should also be aware of potential interactions with other medications and should consult a healthcare provider before starting or stopping any treatment.

Avoid Interactions

Venlafaxine XR 150 mg may interact with other medications, including monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and certain pain relievers. It is also advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects.

Frequently Asked Questions

Venlafaxine XR 150 mg is used to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD).

Venlafaxine XR 150 mg capsules should be taken orally, usually once daily, with or without food. Do not crush or chew the capsules.

Common side effects may include nausea, dizziness, dry mouth, fatigue, insomnia, and constipation.

It is advisable to avoid alcohol while taking Venlafaxine XR 150 mg, as it can increase the risk of side effects.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.